Yahoo Finance • 23 hours ago
We came across a bullish thesis on Tempus AI, Inc. on Emil Hartela Investing’s Substack by Emil. In this article, we will summarize the bulls’ thesis on TEM. Tempus AI, Inc.'s share was trading at $77.33 as of September 25th. TEM’s trailin... Full story
Yahoo Finance • 10 days ago
ARK Invest CEO Cathie Wood recently pointed out that the AI space is ruled by “big four” players: OpenAI, Anthropic, Elon Musk’s xAI, and Google’s (GOOG [https://seekingalpha.com/symbol/GOOG]) Gemini, describing the competition among these... Full story
Yahoo Finance • 14 days ago
Key Points Tempus AI specializes in developing artificial intelligence solutions to improve patient outcomes in various healthcare fields. Ark Invest reduced the Tempus AI position in the ARK Innovation ETF. Tempus AI still holds a signif... Full story
Yahoo Finance • 17 days ago
Below is Validea's guru fundamental report for TEMPUS AI INC (TEM). Of the 22 guru strategies we follow, TEM rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for s... Full story
Yahoo Finance • 20 days ago
We came across a bullish thesis on TransMedics Group, Inc. on Natan’s Substack. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc.'s share was trading at $114.29 as of September 15th. TMDX’s trailing and... Full story
Yahoo Finance • 21 days ago
MarketNewsUpdates News Commentary NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been experiencing significant growth due to... Full story
Yahoo Finance • 29 days ago
Below is Validea's guru fundamental report for TEMPUS AI INC (PRE-REINCORPORATION) (TEM). Of the 22 guru strategies we follow, TEM rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This... Full story
Yahoo Finance • last month
Tempus AI Inc (NASDAQ:TEM [https://www.chartmill.com/stock/quote/TEM]) has become a notable candidate for investors using the Mark Minervini Trend Template with a high growth momentum screen. This two-part method finds stocks showing solid... Full story
Yahoo Finance • last month
Tempus AI, Inc. (NASDAQ:TEM) is one of the best Robinhood stocks to buy right now. On August 22, the company confirmed the acquisition of Paige, an artificial intelligence company specializing in digital pathology, for $81.25 million.Tempu... Full story
Yahoo Finance • last month
Thinking about what to do with Tempus AI shares right now? You are not alone. The stock has been full of surprises for investors looking for the next standout opportunity. After sprinting more than 120% year-to-date, Tempus AI has cemented... Full story
Yahoo Finance • 2 months ago
Investing.com -- Clinical trials are notorious for being expensive and slow, with rising costs and declining efficiency. According to Bernstein, industry R&D spending grew 44% between 2012 and 2022, while the number of novel drug approvals... Full story
Yahoo Finance • 2 months ago
Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Friday after acquiring Paige, an AI company specializing in digital pathology. Tempus is a technology company focused on adopting AI to advance precision medicine. The acquisition a... Full story
Yahoo Finance • 2 months ago
[Using AI technology helps with genetic code prediction research.] Suriphon Singha/iStock via Getty Images * Tempus AI (NASDAQ:TEM [https://seekingalpha.com/symbol/TEM]) said that it will acquire Paige, an AI company focused on digital... Full story
Yahoo Finance • 2 months ago
[M&A Mergers And Acquisitions] narvo vexar Tempus AI (NASDAQ:TEM [https://seekingalpha.com/symbol/TEM]) announced [https://seekingalpha.com/pr/20209187-tempus-announces-the-acquisition-of-paige] on Friday an acquisition of the AI company... Full story
Yahoo Finance • 2 months ago
Investing.com - BTIG raised its price target on Tempus AI Inc (NASDAQ:TEM) to $85.00 from $75.00 while maintaining a Buy rating following the company’s strong second-quarter performance. The stock has shown impressive momentum, deliverin... Full story
Yahoo Finance • 2 months ago
Director Theodore Leonsis sold 44,000 shares of Tempus AI, Inc. NASDAQ:TEM on August 13, 2025. The shares were sold at a price of $69.90, for a total transaction value of $3.07 million. The stock, which has surged 21% in the past week and... Full story
Yahoo Finance • 2 months ago
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Tempus (TEM) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Tempus between August 6, 2024 an... Full story
Yahoo Finance • 2 months ago
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or... Full story
Yahoo Finance • 2 months ago
BENSALEM, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story
Yahoo Finance • 2 months ago
Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Tempus (TEM) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Tempus between August 6, 2024 and May 27,... Full story